Dr Arthur Swift

“I’ve been using these products since 2014, and I haven’t seen one single case of a delayed inflammatory reaction. That’s pretty remarkable.”

Dr Arthur Swift MD, FRCSC

Plastic Surgeon, Montreal, Canada

WHY REVANESSE®

What Makes Revanesse® Unique?

Revanesse® is recognised for its favourable safety profile, with comparative analyses of adverse-event reports in the US Food and Drug Administration’s (FDA) MAUDE database suggesting a low proportion of reported complications relative to certain competing hyaluronic acid dermal fillers. This post-market surveillance data, alongside clinical research, gives medical aesthetic practitioners valuable insight into Revanesse’s safety and performance.

In a comparative clinical study, Revanesse fillers showed lower reported rates of injection-site swelling (47.2% versus 71.2%) and pain (38% versus 66.3%) than a comparator. Together, these findings support Revanesse’s safety profile and provide practitioners with additional confidence when evaluating the brand for their injectable portfolio.

INJECTION-SITE SWELLING

Revanesse 47.2%
Comparator 71.2%

INJECTION-SITE PAIN

Revanesse 38%
Comparator 66.3%

Revanesse® is designed to deliver natural-looking results with reduced post-treatment swelling and discomfort. With less swelling obscuring the immediate outcome, practitioners can assess results more clearly, while patients may experience a more comfortable recovery. Because the filler doesn’t swell significantly hours or days after treatment, the volume you see on the table closely reflects the final aesthetic result. This allows precise volumization without overcorrecting for anticipated post-procedure swelling. The gel reaches its maximum water-absorption and hydration equilibrium during manufacturing; it doesn’t aggressively pull extra fluid from surrounding tissue after injection.

This prevents excessive water attraction (hygroscopic expansion) seen with some other HA fillers, resulting in significantly less localised oedema and downtime. Pre-hydration, combined with the wet-milling process that creates uniform, spherical particles, ensures that the gel slides smoothly through tissue planes. This reduces mechanical friction and acute inflammatory irritation, lowering the risk of early lumpiness, nodules, or foreign-body reactions.

Revanesse® is manufactured in Canada by Prollenium Medical Technologie – North America’s only fully integrated, end-to-end dermal filler manufacturer. Unlike brands that outsource different stages of production, Prollenium oversees the entire manufacturing process, from research and development to production and quality control.

This approach ensures greater control over product consistency, quality and traceability, with selected Revanesse formulations approved by both the US FDA and Health Canada.

Revanesse® offers a distinct commercial advantage: 1.2 ml of hyaluronic acid filler per syringe, compared with the standard 1 ml offered by many competing brands.  This means 20% more product at the same price, giving medical aesthetic practitioners more value per syringe without increasing product costs. For practices looking to optimise treatment costs while maintaining high clinical standards, Revanesse delivers a compelling balance of quality, quantity, and cost efficiency.

Revanesse Volume

Revanesse® continues to push the boundaries of injectable aesthetics, earning an Industry Innovation Award at IMCAS Paris 2026. This achievement highlights the brand’s commitment to advancing aesthetic medicine through science-driven innovation, precision and natural-looking results. Focusing on refined facial enhancement rather than volume alone, Revanesse continues to develop injectable solutions that meet the evolving needs of medical aesthetic practitioners and their patients.

Revanesse Revise IMCAS Award 2026

INNOVATION MEETS PRECISION

What Sets Revanesse® Manufacturing Technology Apart?

Precision-engineered hyaluronic acid fillers manufactured with a proprietary wet milling process that refines HA into uniform, spherical particles.

Unlike irregular, jagged particle structures, spherical HA offers:

  • Enhanced tissue integration → reduced inflammatory response
  • Smooth gel consistency & extrusion force
  • Greater predictability during placement

This process is fundamental to achieving subtle, controlled volumisation. The smooth, uniform particles promote better tissue integration and reduce the risk of a foreign-body reaction.

Revanesse

Long-chain HA is structurally robust and requires significantly less BDDE (1,4-butanediol diglycidyl ether) cross-linking agent to achieve structural integrity.

  • Optimised Biocompatibility: Minimise residual BDDE to lower the risk of foreign body reactions and delayed-onset nodules.
  • Thixofix® Technology: Advanced cross-linking for superior gel stability, structural integrity, and clinical performance.
  • Extended 7-Day Purification: Removes excess unreacted BDDE to maximise overall gel purity.
Optimised Cross-Linking

Clinical split-face trials highlight a distinct patient-recovery advantage. Revanesse fillers have demonstrated significantly lower patient-reported post-treatment swelling and reduced injection-site discomfort.

This is due to:

  • Cross-linking structure limits this post-injection volumetric expansion.
  • Smooth, uniform particles due to the wet milling process
  • Biocompatibility of the HMW HA associated with less inflammatory macrophage activation
  • Less chemical modification means fewer irritants enter the dermal tissue, reducing acute neurosensory activation and localised inflammatory pain responses.
  • Lower injection pressure translates to less localised barotrauma and mechanical tearing of the tissue matrix, directly decreasing patient discomfort

Revanesse® uses its proprietary Thixofix® Technology to manufacture highly refined, cross-linked hyaluronic acid dermal fillers. BDDE (1,4-butanediol diglycidyl ether) is a cross-linking agent used to improve the stability and longevity of hyaluronic acid gels. Through carefully controlled manufacturing and extended purification processes, Revanesse aims to minimise residual, unreacted BDDE in the finished product.

This focus on gel purity and manufacturing precision is an important consideration for medical aesthetic practitioners evaluating filler quality, biocompatibility and patient safety.

SHOP THE RANGE
Comparison criteria Revanesse Pure Revanesse Pure Revanesse Revise Revanesse Kiss + Revanesse Kiss Revanesse Ultra + Revanesse Ultra Revanesse Outline + Revanesse Outline Revanesse Contour Revanesse Shape + Revanesse Shape Revanesse Sculpt
HA CONCENTRATION 14 mg/mL 12 mg/mL 25 mg/mL 25 mg/mL 25 mg/mL 25 mg/mL 25 mg/mL 25 mg/mL
VISCOSITY 0 out of 8 1 out of 8 2 out of 8 3 out of 8 5 out of 8 4 out of 8 6 out of 8 7 out of 8
PARTICLES SIZE
LIFTING CAPACITY Very Low Low Low Moderate High Moderate / High Very High Very High
INJECTION DEPTH Superficial Dermis Superficial to mid-dermis Superficial to mid-dermis Mid-to-deep dermis Deep dermis to subcutaneous Deep dermis to subcutaneous Supra-periosteum Supra-periosteum
COMMONLY TREATED AREAS Ermerging lines Tear troughs
& Perioral line
Lips & Perioral lines Submalar areas, Nasolabial folds,
Marionette lines, Oral commissures
Vermilion border, Philtral column,
& Lips
Cheeks & Temples Lateral cheeks,
Jawline & Chin
Lower face,
Jawline & Chin
NR OF SYRINGES & VOLUME 2×1.2 mL 2×1.2 mL 2×1.2 mL 2×1.2 mL 2×1.2 mL 2×1.2 mL 2×1.2 mL 2×1.2 mL
NEEDLE SIZE IN THE PACK 30G 30G 30G 27G Available with
29G or 27G
27G 27G 27G

EVERYTHING YOU NEED TO KNOW

Frequently Asked Questions

Aesthetic Connection offers a tiered pricing structure based on order volume, allowing medical aesthetic practitioners to benefit from volume-based pricing as their purchasing quantities increase. To access product pricing and view the discounts available to your practice, simply register for a professional account. For added convenience, we offer flexible payment options, including credit card payments, electronic funds transfer (EFT) and a 30-day credit facility for qualifying practices, subject to approval.

Credit card payments may also offer additional benefits, such as Discovery Miles, FNB eBucks, cashback and other loyalty rewards, depending on your bank and card provider. Some cards may also offer interest-free repayment periods, giving you more flexibility in managing your practice’s cash flow.

Yes, Aesthetic Connection offers complimentary delivery on all orders, ensuring a convenient and cost-effective purchasing experience. Next-day delivery is available in major metropolitan areas, including Johannesburg, Pretoria and Cape Town, while deliveries to outlying areas typically take 2–3 working days. Our efficient delivery service helps practitioners maintain consistent stock levels and minimise practice disruptions.